- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07827703
Effects of Digital Detox on Mental Health in Young Adults
Effects of Digital Detox on Mental Health in Young Adults: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether a short, self-guided program for cutting down smartphone screen time can reduce symptoms of depression in young adults. It includes students in Oslo, Norway, who have applied for help at the student mental health service (SiO Mental Health).
The main questions it aims to answer are:
- Does a 2-week screen time reduction program reduce symptoms of depression?
- Does it reduce symptoms of anxiety?
- Can a simple, widely available phone app reduce screen time, and does the reduction last?
Researchers will compare students who start the program right away with students who continue their usual care for 2 weeks and receive the same program afterwards. Participants are placed in one of the two groups by chance, like flipping a coin.
Participants will:
- Answer questionnaires about depression and anxiety symptoms at the start and again after 2 weeks
- Upload screenshots of the Screen Time summary on their iPhone at the start, after 2 weeks, and after 12 weeks
- Install an app that blocks the apps they find most distracting and keep it active for 2 weeks, if they are placed in the program group
- Take part entirely online, with no clinic visits and no contact with the study team
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Thomas Mildestvedt, Professor
- Numéro de téléphone: +47 55586163
- E-mail: thomas.mildestvedt@uib.no
Lieux d'étude
-
-
-
Oslo, Norvège
- Studentsamskipnaden i Oslo
-
Contact:
- Thomas Mildestvedt, Professor
- Numéro de téléphone: +47 55586163
- E-mail: thomas.mildestvedt@uib.no
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Has applied for care at SiO Mental Health, the student mental health service in Oslo, and has received the service's response to the application
- Owns an iPhone (the screen time restriction tool requires iOS)
- Able to understand written Norwegian
- Provides informed consent
Exclusion Criteria:
- None
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Prendre soin comme d'habitude
|
|
|
Expérimental: Screen time reduction
|
Two-week self-guided use of an iOS screen time restriction app. Participants block their most distracting apps, with notifications disabled. Unlocking requires a 30-second delay, allows 10 minutes of access, then a 5-minute cooldown. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Symptoms of depression (PHQ-9)
Délai: From enrollment to the end of intervention at 2 weeks
|
Patient Health Questionnaire-9, range 0 to 27, higher scores indicate more depressive symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Total smartphone screen time
Délai: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Smartphone screen time by app category
Délai: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Number of daily smartphone pickups
Délai: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Symptoms of anxiety (GAD-7)
Délai: From enrollment to the end of intervention at 2 weeks
|
Generalized Anxiety Disorder-7, range 0 to 21, higher scores indicate more anxiety symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Self-reported changes in daily functioning and well-being
Délai: 2 weeks
|
Twelve single-item questions on perceived change over the past 2 weeks, each answered on a 5-point scale from 1 (much less than usual) to 5 (much more than usual). The domains are sleep, time spent with others, physical activity, time on other screens (computer, tablet), loneliness, satisfaction with oneself, rumination on negative thoughts, feeling of missing out, stress, ability to concentrate, satisfaction with own study effort, and getting done what one plans. Higher scores indicate more of the attribute than usual. Whether a higher score represents a better outcome depends on the domain. |
2 weeks
|
|
Adherence to the screen time restriction tool
Délai: 2 weeks
|
Self-reported proportion of the 2-week period with the blocking rule kept active, answered on a 5-level ordinal scale: all of the time, most of the time, part of the time, little of the time, none. Higher levels indicate greater adherence. Reported by the intervention group. |
2 weeks
|
|
Perceived usefulness and burden of the tool
Délai: 2 weeks and 12 weeks
|
Perceived usefulness of the tool for reducing screen time and perceived burden in everyday life, each answered on a 5-point scale from 1 (not at all) to 5 (to a very great extent), and a single question on intention to continue use (yes, no, do not know). Higher usefulness indicates a better outcome and higher burden a worse outcome. Reported by the intervention group at 2 weeks and by both groups at 12 weeks. |
2 weeks and 12 weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Thomas Mildestvedt, Professor, University of Bergen
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1000700
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Anonymized individual participant data underlying the published results.
Délai de partage IPD
After publication of the primary results.
Critères d'accès au partage IPD
Upon request to the principal investigator, under a data sharing agreement.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .